Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia
- 24 November 2003
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 20 (12) , 1027-1033
- https://doi.org/10.1111/j.1464-5491.2003.01054.x
Abstract
Aims To evaluate the risk of diabetes in subjects with impaired fasting glycemia (IFG) as compared with impaired glucose tolerance (IGT) and normal glucose tolerance. Methods Men (1223) and women (1370) aged 45–64 years and free of diabetes at baseline were followed‐up for 10 years, with 26 737 person years accumulated. The incident diabetic cases were identified through the national Drug Register and the Hospital Discharge Register. Results During the 10 years of follow‐up, 53 (4.3%) men and 47 (3.4%) women developed diabetes. IFG alone defined 22 (15.5/1000 person years) diabetic cases, which was higher than for subjects with normal fasting glucose. Subjects with isolated IGT identified an additional 34 cases (155% more) which could not be defined by IFG alone. The area under the ROC curve was larger for 2‐h glucose (0.77, 95% CI 0.72–0.82) than for fasting glucose (0.65, 0.58–0.71). The multivariate adjusted Cox hazard ratio was higher for isolated IGT (3.9, 95% CI 2.4–6.2) than for isolated IFG (2.3, 0.9–5.7) as compared with subjects with neither IFG nor IGT. Conclusion Both IFG and IGT are risk predictors for diabetes, but IGT defines a much larger target population for prevention.Keywords
This publication has 20 references indexed in Scilit:
- Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucoseEuropean Heart Journal, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceNew England Journal of Medicine, 2001
- Glucose Tolerance and Cardiovascular MortalityArchives of internal medicine (1960), 2001
- Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteriaThe Lancet, 1999
- The STOP-NIDDM Trial: An international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening dataDiabetes Care, 1998
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 1997
- Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes StudyDiabetes Care, 1997
- Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malm feasibility studyDiabetologia, 1991
- Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose IntoleranceDiabetes, 1979